LIPOCINE INC. Interest Expense
LIPOCINE INC. (LPCN) reported Interest Expense of $27.10 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-07.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-03-07
- LIPOCINE INC. interest expense for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- LIPOCINE INC. interest expense for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- LIPOCINE INC. interest expense for the quarter ending 2022-06-30 was $7.57K, a 86.82% decline year-over-year.
- LIPOCINE INC. interest expense for the quarter ending 2022-03-31 was $19.53K, a 71.69% decline year-over-year.
- LIPOCINE INC. interest expense for fiscal 2022 was $27.10K, a 86.67% decline from fiscal 2021.
- LIPOCINE INC. interest expense for fiscal 2021 was $203.29K, a 47.42% decline from fiscal 2020.
- LIPOCINE INC. interest expense for fiscal 2020 was $386.62K, a 49.58% decline from fiscal 2019.
- LIPOCINE INC. interest expense for fiscal 2019 was $766.75K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $0.00 derived: sum of 2 quarters · filed 2024-03-07 | $7.57K derived: sum of 3 quarters · filed 2024-03-07 | $27.10K 10-K · filed 2024-03-07 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $7.57K derived: sum of 2 quarters · filed 2023-11-08 | $27.10K 10-Q · filed 2023-11-08 | $59.15K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $7.57K 10-Q · filed 2023-08-10 | $27.10K 10-Q · filed 2023-08-10 | $59.15K derived: sum of 3 quarters · filed 2023-08-10 | $103.99K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $19.53K 10-Q · filed 2023-05-11 | $51.58K derived: sum of 2 quarters · filed 2023-05-11 | $96.42K derived: sum of 3 quarters · filed 2023-05-11 | $153.85K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $32.05K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $76.89K derived: sum of 2 quarters · filed 2023-03-10 | $134.32K derived: sum of 3 quarters · filed 2023-03-10 | $203.29K 10-K · filed 2023-03-10 |
| 2021-09-30 | $44.84K 10-Q · filed 2022-11-09 | $102.27K derived: sum of 2 quarters · filed 2022-11-09 | $171.24K 10-Q · filed 2022-11-09 | $252.37K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $57.43K 10-Q · filed 2022-08-08 | $126.40K 10-Q · filed 2022-08-08 | $207.53K derived: sum of 3 quarters · filed 2022-08-08 | $291.83K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $68.97K 10-Q · filed 2022-05-09 | $150.11K derived: sum of 2 quarters · filed 2022-05-09 | $234.40K derived: sum of 3 quarters · filed 2022-05-09 | $322.25K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $81.13K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $165.43K derived: sum of 2 quarters · filed 2022-03-09 | $253.27K derived: sum of 3 quarters · filed 2022-03-09 | $386.62K 10-K · filed 2022-03-09 |
| 2020-09-30 | $84.29K 10-Q · filed 2021-11-10 | $172.14K derived: sum of 2 quarters · filed 2021-11-10 | $305.49K 10-Q · filed 2021-11-10 | $460.37K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $87.85K 10-Q · filed 2021-08-05 | $221.19K 10-Q · filed 2021-08-05 | $376.07K derived: sum of 3 quarters · filed 2021-08-05 | $559.57K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $133.34K 10-Q · filed 2021-05-06 | $288.23K derived: sum of 2 quarters · filed 2021-05-06 | $471.73K derived: sum of 3 quarters · filed 2021-05-06 | $676.30K derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $154.88K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $338.38K derived: sum of 2 quarters · filed 2021-03-11 | $542.96K derived: sum of 3 quarters · filed 2021-03-11 | $766.75K 10-K · filed 2021-03-11 |
| 2019-09-30 | $183.50K 10-Q · filed 2020-11-10 | $388.07K derived: sum of 2 quarters · filed 2020-11-10 | $611.86K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $204.57K 10-Q · filed 2020-08-06 | $428.36K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $223.79K 10-Q · filed 2020-05-07 | |||
| 2018-09-30 | $218.58K 10-Q · filed 2019-11-12 | $430.07K derived: sum of 2 quarters · filed 2019-11-12 | $622.54K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $211.49K 10-Q · filed 2019-08-07 | $403.96K 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $192.47K 10-Q · filed 2019-05-08 | |||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $0.00 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-07 | $0.00 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |